AnalystRadar
FATE Updated Aug 13, 2026

Fate Therapeutics, Inc. (FATE)

Analyst consensus, price target and coverage. 9 analysts, updated daily.

Consensus Buy= Unchanged
Price 2.72 USD
Mean target 5.41 USD
Upside +98.9% target vs price
Market cap Small 0.3B

Analyst votes

How the ratings break down

12 ratings on record

Price targets

Where the estimates sit

How far apart analysts are on this name.

Low 2.20 Mean 5.41 High 8.00

share price 2.72 mean target 5.41. Analysts are spread 264% apart.

Most recent action

Last rating change

FirmHC Wainwright & Co.
Date2026-06-08
ChangeBuy → Buy

Size and liquidity

Key statistics

Market cap0.32B USD
Cap classSmall
Average volume3,828,512
Dollar volume per day10.4M
LiquidityHigh
Internal score80.2 / 100

Recommendation

How it moved, scan by scan

2 scans on record

ScanMoveConsensusScoreSBBuyHoldUndSell
2026-08-13 = Buy 2.42 1 5 6 0 0
2026-08-11 · Buy 2.42 1 5 6 0 0

Score is the analyst average on Yahoo's scale, where 1 is Strong Buy and 5 is Sell, so a falling number means the view improved. more positive, more negative, = unchanged.

History

Price target over time

2 daily points recorded

DatePriceTargetUpsideConsensus
2026-08-13 2.72 5.41 +98.9% Buy
2026-08-11 2.73 5.41 +98.2% Buy

Similar coverage

Comparable small-cap names

Closest upside among companies of the same size.

← All 1035 companies in the screener